RoB 2: a revised tool for assessing risk of bias in randomised trials | BMJ, The | 2019 | 3.8K |
Frailty: implications for clinical practice and public health | Lancet, The | 2019 | 478 |
Apixaban to Prevent Venous Thromboembolism in Patients with Cancer | New England Journal of Medicine | 2019 | 391 |
An atlas of genetic influences on osteoporosis in humans and mice | Nature Genetics | 2019 | 270 |
Genomic and transcriptomic profiling expands precision cancer medicine: the WINTHER trial | Nature Medicine | 2019 | 205 |
Nivolumab for Relapsed/Refractory Diffuse Large B-Cell Lymphoma in Patients Ineligible for or Having Failed Autologous Transplantation: A Single-Arm, Phase II Study | Journal of Clinical Oncology | 2019 | 173 |
Cardiovascular Disease-Related Morbidity and Mortality in Women With a History of Pregnancy Complications | Circulation | 2019 | 159 |
Perioperative Management of Patients With Atrial Fibrillation Receiving a Direct Oral Anticoagulant | JAMA Internal Medicine | 2019 | 156 |
Pembrolizumab in relapsed or refractory Hodgkin lymphoma: 2-year follow-up of KEYNOTE-087 | Blood | 2019 | 148 |
Polatuzumab vedotin or pinatuzumab vedotin plus rituximab in patients with relapsed or refractory non-Hodgkin lymphoma: final results from a phase 2 randomised study (ROMULUS) | Lancet Haematology,the | 2019 | 108 |
Mosunetuzumab Induces Complete Remissions in Poor Prognosis Non-Hodgkin Lymphoma Patients, Including Those Who Are Resistant to or Relapsing After Chimeric Antigen Receptor T-Cell (CAR-T) Therapies, and Is Active in Treatment through Multiple Lines | Blood | 2019 | 105 |
Endovascular Thrombus Removal for Acute Iliofemoral Deep Vein Thrombosis | Circulation | 2019 | 104 |
Antibiotics are associated with decreased progression-free survival of advanced melanoma patients treated with immune checkpoint inhibitors | OncoImmunology | 2019 | 91 |
Association of Aripiprazole With the Risk for Psychiatric Hospitalization, Self-harm, or Suicide | JAMA Psychiatry | 2019 | 82 |
The negative impact of antibiotics on outcomes in cancer patients treated with immunotherapy: a new independent prognostic factor? | Annals of Oncology | 2019 | 82 |
The sinister face of heme oxygenase-1 in brain aging and disease | Progress in Neurobiology | 2019 | 81 |
Randomized Phase II Study Evaluating Palbociclib in Addition to Letrozole as Neoadjuvant Therapy in Estrogen Receptor-Positive Early Breast Cancer: PALLET Trial | Journal of Clinical Oncology | 2019 | 80 |
Interim Results from the IMPACT Study: Evidence for Prostate-specific Antigen Screening in BRCA2 Mutation Carriers | European Urology | 2019 | 78 |
121 The Cumulative Effect of Evidence-Based Practices on Outcomes of Preterm Infants Born <29 Weeks | Paediatrics and Child Health | 2019 | 78 |
1187. Estimation of Individual Healthcare Workers’ Relative Hand Hygiene Compliance Using an Anonymous Electronic Monitoring System | Open Forum Infectious Diseases | 2019 | 78 |
2301. Increased Risk of Varicella-Associated Hospitalizations Among Adult Immigrants From Temperate and Tropical Countries After the Introduction of a Childhood Varicella Vaccination Program in Quebec, Canada | Open Forum Infectious Diseases | 2019 | 78 |
A systematic meta-review of predictors of antidepressant treatment outcome in major depressive disorder | Journal of Affective Disorders | 2019 | 70 |
Nivolumab Combined With Brentuximab Vedotin for Relapsed/Refractory Primary Mediastinal Large B-Cell Lymphoma: Efficacy and Safety From the Phase II CheckMate 436 Study | Journal of Clinical Oncology | 2019 | 63 |
Phase Ib study of atezolizumab combined with cobimetinib in patients with solid tumors | Annals of Oncology | 2019 | 59 |
EAES and SAGES 2018 consensus conference on acute diverticulitis management: evidence-based recommendations for clinical practice | Surgical Endoscopy and Other Interventional Techniques | 2019 | 58 |